SciRise Logo
    Insights

    The Gates Foundation's Grantmaking Portfolio, on the Eve of Its Spend-Down

    May 25, 2026Michael J. Fern

    Foundation Portfolio Analysis · 2022–2024

    What three years of filings reveal about one of the world's largest private foundations, on the eve of its announced spend-down.

    Analysis dateData sourceTax years
    2026 · 05 · 26IRS 990-PF Schedule I2022–2024
    Grant recordsRecipientsTotal dollars
    13,507~3,323 distinct$18.3B

    Download the full report (PDF)


    A Note to the Reader

    Throughout this report, claims are tagged according to how directly they are supported by the underlying data. [DATA] marks figures and patterns drawn straight from IRS 990 filings. [INFERRED] marks interpretations that go beyond the raw counts, where analytical judgment is required and alternative explanations remain possible. [REPORTED] marks claims in the 2045 spend-down section that are drawn from the foundation's own public statements and authoritative journalism rather than from the tax filings.

    The portfolio described here is what Gates did fund, not what it set out to fund or what it considered. Selection criteria, declined applications, and the broader universe of eligible recipients are not visible in this data and should not be inferred from it. Two structural caveats shape every finding: roughly 47 percent of grant dollars flow to international recipients (multilaterals, foreign universities, international NGOs) that do not file U.S. returns, and the matched U.S. portion separates into 501(c)(3) nonprofits, universities, and for-profit/other entities (a full reconciliation appears in §03). And a three-year window cuts every multi-decade relationship at both ends.

    This report is part of a comparative foundation-analysis series; occasional contrasts with the MacArthur Foundation appear where they sharpen the structural reading of Gates's portfolio.


    §01 · Executive Summary

    The Portfolio at a Glance

    This analysis examines every grant made by the Gates Foundation (formerly the Bill & Melinda Gates Foundation) across tax years 2022 to 2024, drawn from IRS Form 990-PF Schedule I and resolved against the full U.S. 501(c)(3) population. The dataset captures 13,507 grants totaling $18.3 billion to approximately 3,323 distinct recipient organizations. The window is the three most recent complete annual returns available in the public IRS e-file extracts.

    Five Findings

    1. This is a global health foundation first, and everything else second. [DATA] Counting by stated grant purposes, vaccines and immunization absorb 27 percent of dollars, infectious and neglected diseases (including malaria, TB, HIV, and enteric diseases) absorb 21 percent, and maternal, newborn and child health absorbs 14 percent. Polio eradication alone absorbed $2.4 billion, 13 percent of all giving across the window. U.S. education is the one major theme that sits outside the global health and development core, at 17 percent.

    2. Nearly half the money goes overseas, and the single biggest destination is Geneva. [DATA] [INFERRED] International recipients received 47 percent of all dollars. Switzerland alone accounted for 16 percent, not because the foundation funds Swiss causes, but because the major multilateral health institutions (Gavi, the Global Fund, WHO, Medicines for Malaria Venture) are headquartered there. Read in this light, the foundation is the principal private co-financier of the Geneva-based global health architecture.

    3. The portfolio runs through a small set of very large institutional channels. [DATA] The top 10 recipients absorbed 30 percent of all dollars and the top 100 took 57 percent. Gavi ($1.0B), the Global Fund ($857M), and the World Health Organization (about $1.1B aggregated across its country offices) are not grantees in the ordinary sense; they are global financing platforms the foundation co-funds.

    4. Gates is a renewing, long-horizon funder, not a one-time grantmaker. [DATA] Organizations funded in all three years made up just 30 percent of recipients but received 83 percent of the dollars. A one-time grant in this portfolio is small and rare in dollar terms (6 percent of giving). The depth of repeat funding is the defining structural feature.

    5. The "average" grant is not the story; the big bets are. [DATA] The median grant was $500,000, but 23 grants of $50 million or more carried 19 percent of all giving, and the 443 grants of $5 million or more carried 43 percent. This is a barbell: many mid-size program grants underneath a handful of nine-figure platform commitments.


    §02 · Forward Signal — The 2045 Spend-Down

    Unlike the rest of this report, this section is not drawn from tax filings. It summarizes the foundation's own May 2025 announcement and subsequent statements, and authoritative journalism about them, cited inline and listed in the references. Claims here are tagged [REPORTED].

    [REPORTED] On May 8, 2025, marking its 25th anniversary, the Gates Foundation announced it will close permanently in 2045 and spend more than $200 billion between 2025 and 2045, roughly doubling its giving over the next two decades. The board amended the foundation's charter, which had previously committed it to sunset 20 years after Bill Gates's death; the new plan sets a fixed end date instead. [1][2]

    "There are too many urgent problems to solve for me to hold onto resources that could be used to help people. That is why I have decided to give my money back to society much faster than I had originally planned." — Bill Gates

    [REPORTED] Bill Gates framed the decision in a public letter, committing 99 percent of his remaining fortune to the foundation over the next two decades. The foundation has given more than $100 billion since its founding in 2000. [1][2]

    [REPORTED] In the near term, the foundation expects to reach about $9 billion in annual distributions in 2026, with CEO Mark Suzman indicating a sustained $9 to $10 billion annual range. The announced endowment of roughly $77 billion is consistent with the $78.7 billion in assets shown on the 2024 return analyzed in this report. [2][3][4]

    [REPORTED] The timing is pointed. The announcement came after the U.S. initiated withdrawal from WHO in January 2025 and amid broader global-aid disruption: the U.S. moved to dissolve USAID and reorganize foreign assistance under the State Department, and cut significant global health funding. Those disruptions deepened in January 2026, when the U.S. announced it had completed its WHO withdrawal (effective January 22, 2026, one year after notification). Suzman warned that 2025 "is likely to be the first year of this century where preventable child mortality actually rises rather than declines." [2][9]

    Stated priorities for the next two decades [REPORTED]: End preventable deaths of mothers and babies. Ensure the next generation grows up without deadly infectious diseases. Lift millions of people out of poverty. The foundation also names U.S. student pathways, digital public infrastructure, applications of artificial intelligence, and gender equality as continuing areas of work. [1]

    A Note of Caution on the Headline Number

    [REPORTED] Some philanthropy analysts question whether $200 billion represents a true spend-down of principal. Inside Philanthropy notes that at the foundation's historical investment returns (a roughly 9 percent five-year average; about 5.7 percent even at the S&P 500's long-run inflation-adjusted return), a $9 to $10 billion annual budget could be funded largely or entirely from investment gains, meaning the endowment "might well grow, not shrink." On that math, the $200 billion figure may understate what the foundation could spend or, conversely, may not require it to draw down principal at all before 2045. The actual total will depend on markets, inflation, and the pace of Gates's incoming contributions. [5]

    Why This Matters for Reading the Portfolio Above

    [REPORTED] [INFERRED] A doubling of annual giving toward $9 billion-plus, against a fixed 2045 horizon, points toward larger checks to institutions that can absorb them rather than a broader base of smaller grantees, reinforcing the barbell and the multi-year institutional pattern documented later in this report. A spend-down funder also has a structural incentive to favor durable, scalable platforms (Gavi, the Global Fund, large research institutions) over long-tail seeding, since there is a finite window to deploy capital. The three global-health-and-development priorities named for the wind-down map directly onto the portfolio's three largest demonstrated themes.

    An Operationally Leaner Foundation

    [REPORTED] On January 14, 2026, the foundation's board endorsed a historic $9 billion annual payout for 2026 and approved a cap on annual operating expenditures of no more than $1.25 billion, roughly 14 percent of the budget. To meet that cap, the foundation will reduce headcount by up to 500 positions, roughly 20 percent of staff, by 2030 (with the first 200 by the end of 2027), through attrition and layoffs. [6][7]

    [REPORTED] Separately, in spring 2026, the foundation commissioned an external review of past foundation engagement with Jeffrey Epstein, first reported by the Wall Street Journal in April. [7][8]

    [REPORTED] [INFERRED] The operating-expense cap is the more structurally informative of the two announcements for a portfolio reader. A budget that doubles while headcount shrinks likely increases pressure to concentrate capital into larger, more standardized institutional channels. That is the same direction the demonstrated 2022 to 2024 portfolio already points.


    §03 · Findings by Dimension

    Scale and Giving

    [DATA] The Gates Foundation held $78.7 billion in assets at the end of tax year 2024 and paid out roughly $5.75 billion (2022), $6.23 billion (2023), and $6.31 billion (2024), totaling $18.3 billion across the three-year window. The foundation is a December fiscal-year filer; tax year equals calendar year. Extracted grant totals reconcile to 100 percent of the official Part I grants-paid figure in all three years.

    Annual grant statistics · 2022–2024

    Tax yearGrantsMedianMeanSmallestLargest
    20223,994$525,361$1,439,574$2,500$340.0M
    20234,539$501,031$1,373,433$1,000$340.0M
    20244,974$500,000$1,268,830$1$350.5M

    [DATA] The pooled median across all 13,507 grants is $500,000. The mean exceeds the median in every year, reflecting the long right tail pulled up by the largest commitments.

    [INFERRED] The median has drifted down and the mean down with it across the three years, even as the dollar total rose, consistent with a growing count of mid-size grants beneath a stable set of very large platform commitments.

    Recipient-type reconciliation · $18.29B total [DATA]

    Destination / recipient typeDollarsShare
    International (multilaterals, foreign universities, foreign NGOs)$8.56B46.8%
    U.S. destination, total$9.74B53.2%
    — 501(c)(3) nonprofits (NTEE-table basis)$9.39B51.3%
    — U.S. universities (matched separately)$154M0.8%
    — For-profit and other U.S. entities (residual)~$200M~1.1%

    For-profit and other U.S. recipients are dominated by Pfizer ($127.8 million across six grants, including two $50M pneumonia and pandemic-preparedness grants). Findings keyed to U.S. tax classifications (sector, maturity, revenue) describe the 501(c)(3) subset only; findings keyed to the foundation's own grant-purpose text (issue clusters, gift sizing, big bets) cover the full portfolio.

    Geography

    [DATA] Roughly half the foundation's grant dollars flow outside the United States, an unusually international footprint for a U.S. private foundation.

    Domestic vs international distribution

    DestinationGrantsDollars (B)% of total
    United States7,598$9.7453.2%
    International5,909$8.5646.8%

    International recipients · by country

    CountryDollars (M)% of total
    Switzerland (Geneva multilaterals)$2,95016.1%
    United Kingdom$8494.6%
    India$5312.9%
    Kenya$4842.6%
    South Africa$4002.2%
    Nigeria$3381.8%
    Pakistan$3301.8%

    [DATA] [INFERRED] The Switzerland figure is the single most misread number in any naive read of these filings. It does not represent funding for Switzerland; it represents the foundation's role as a co-financier of the Geneva-based global health architecture. Read alongside the recipient list, the international portfolio is overwhelmingly about disease-specific delivery in low- and middle-income countries, channeled through multilateral institutions.

    [DATA] Below the top seven, the international portfolio has a long, geographically wide tail. Grants flowed to 100-plus countries and territories, with 31 additional jurisdictions receiving three-year totals of roughly $30 million to $300 million.

    International Long Tail

    [DATA] Below the top seven country destinations, grants flowed to more than 100 countries and territories. The 31 jurisdictions with three-year totals of roughly $30 million to $300 million, in order:

    CountryDollarsCountryDollars
    France$231.0MBangladesh$56.1M
    Canada$195.4MGhana$45.9M
    Germany$154.2MJapan$44.9M
    Mexico$119.1MSenegal$44.6M
    China$115.9MAfghanistan$44.4M
    Ethiopia$106.7MPhilippines$39.9M
    Congo (Brazzaville)$103.7MTanzania$38.5M
    Italy$100.4MUganda$37.6M
    Belgium$99.2MIndonesia$37.0M
    Norway$98.0MPeru$34.8M
    South Korea$95.4MDenmark$34.4M
    Netherlands$86.2MZambia$34.3M
    Australia$78.9MZimbabwe$33.3M
    Singapore$77.0MFinland$29.7M
    Saudi Arabia$65.6MColombia$29.7M
    Côte d'Ivoire$29.7M

    [DATA] Below $30 million, more than 60 additional countries and territories received smaller amounts (101 non-U.S. jurisdictions in total). Country attributions follow the IRS filing's country codes.

    U.S. Geography

    [DATA] Within the United States, giving concentrates where research universities, multilateral-adjacent NGOs, and policy institutions cluster. The pattern is coastal, capital, and home-state rather than place-based community giving.

    Top U.S. jurisdictions by dollars

    StateDollars (M)% of all giving% of U.S. giving
    New York$1,89010.3%19.4%
    Washington, DC$1,5908.7%16.3%
    Massachusetts$1,5608.5%16.0%
    Washington (home state)$1,1206.1%11.5%
    California$9185.0%9.4%

    [DATA] The top five U.S. jurisdictions account for roughly 72 percent of all U.S. giving and 38 percent of total giving. These state totals are driven by a handful of named institutions, not broad in-state giving.

    [DATA] [INFERRED] Unlike many large foundations, Gates shows only modest home-state concentration. Washington State received 6 percent of dollars, less than New York or even DC. This is consistent with a mission defined by global problems rather than place-based community giving.

    The geographic story is not place-based at all. It is institutional: Gates funds wherever the relevant biomedical research, multilateral architecture, or country-level delivery capacity sits, and those institutions happen to cluster in Geneva, New York, Boston, and Washington.

    Who Drives Each State Total

    [DATA] [INFERRED] State totals are concentrated in a small number of named recipients, almost all of them global-health or research institutions rather than local causes. The top recipients in each leading state, three-year totals:

    • New York · $1.89B: U.S. Fund for UNICEF ($652.4M), Pfizer ($127.8M), International AIDS Vaccine Initiative ($71.2M), UN Population Fund ($52.7M), Global Alliance for TB Drug Development ($51.8M).
    • Washington, DC · $1.59B: International Bank for Reconstruction and Development / World Bank ($349.9M), New Venture Fund ($110.6M), eHealth Africa ($84.1M), UN Foundation ($51.8M), Population Services International ($51.6M).
    • Massachusetts · $1.56B: Gates Medical Research Institute ($620.8M), Clinton Health Access Initiative ($188.9M), Harvard ($96.0M), Massachusetts General Hospital ($86.6M), JSI Research & Training ($67.5M).
    • Washington, home state · $1.12B: PATH ($444.5M), University of Washington Foundation ($282.2M), VillageReach ($33.9M), Fred Hutchinson Cancer Center ($26.5M), Lakeside School ($25.2M).
    • California · $918M: Stanford ($69.5M), Hispanic Scholarship Fund ($69.1M), UC San Francisco ($63.8M), Scripps Research Institute ($56.3M), Advanced Education Research & Development Fund ($35.0M).

    The pattern confirms the institutional reading. DC giving runs through multilateral and policy bodies. Massachusetts is dominated by the foundation's own affiliated research institute plus Boston-area medicine. Even the home-state total is mostly two global-health implementers (PATH and the University of Washington) rather than local causes.

    Issue-Area Concentration

    [DATA] Grant-purpose text identifies the foundation's working themes across the full portfolio, including the unmatched international portion. Clusters overlap by design (a single grant can be both a vaccine grant and a child-health grant), so shares do not sum to 100 percent.

    Cluster (purposes overlap)GrantsDollars (B)Share
    Vaccines and immunization1,094$4.9326.9%
    Malaria / TB / HIV / neglected tropical disease2,232$3.8621.1%
    U.S. education and learning2,979$3.1217.0%
    Maternal, newborn and child health1,193$2.4713.5%
    Discovery and translational sciences1,460$2.4113.2%
    Polio eradication432$2.3612.9%
    Family planning / women and girls1,453$1.9410.6%
    Agricultural development1,050$1.548.4%
    Pandemic preparedness332$1.075.8%
    Financial services / economic mobility476$0.613.3%
    Water, sanitation and hygiene287$0.261.4%

    [DATA] [INFERRED] U.S. education is the one large theme that sits outside the global health and development core; it is the visible footprint of the foundation's U.S. Program, covering K-12, postsecondary completion, and charter-adjacent funds. Everything else in the top tier is a global health or global development line.

    The vocabulary of the grant purposes is unambiguous: vaccine, polio, malaria, maternal, newborn, child, nutrition, agricultural, tuberculosis, pneumonia, diagnostics, genomics, epidemiology, family planning. This is a foundation with a tightly bounded thesis.

    Polio Eradication: Where the $2.36B Went

    [DATA] Polio-tagged grants (purpose text contains "polio") totaled $2.36 billion over three years, concentrated in a small set of named channels:

    Recipient3-yr polio total
    World Health Organization (all offices)$749.5M
    U.S. Fund for UNICEF$482.9M
    Rotary Foundation$320.5M
    PATH$152.6M
    eHealth Africa$83.5M
    RIZ Consulting (Pakistan)$63.6M
    Islamic Development Bank$40.2M
    Biological E Limited (India)$27.3M
    SCIDAR (Nigeria)$25.8M
    Results Educational Fund$22.7M

    [DATA] WHO, UNICEF, and Rotary — three historic core partners of the Global Polio Eradication Initiative — together account for the large majority of the foundation's polio spend. The remainder is a long tail of implementing organizations, mostly in Pakistan, Nigeria, and the DRC. The National Foundation for the CDC received only about $3.9 million in polio-tagged grants in this window.

    Sector Comparison Against Base Rates

    [DATA] The figures below describe the matched-to-nonprofit portion of the portfolio ($9.39 billion, 51.3 percent of dollars), the NTEE-eligible subset. University-only matches ($154M, 0.8 percent) are excluded from this table, which modestly understates Education (B).

    NTEE major code · Gates weighting vs sector base rate

    CodeDescriptionGates %Sector %Ratio
    QInternational, foreign affairs38.3%2.2%17.7×
    VSocial science1.6%0.2%6.7×
    HMedical research2.1%0.7%3.0×
    BEducation26.5%18.4%1.4×
    EHealth care11.1%10.7%1.0×
    SCommunity improvement / development4.4%5.1%0.9×
    TPhilanthropy / grantmaking3.3%4.1%0.8×
    CEnvironment1.3%2.8%0.5×
    FMental health1.0%3.4%0.3×
    AArts, culture, humanities1.1%6.4%0.2×
    PHuman services2.4%16.4%0.1×
    Other categories + uncoded6.7%

    "Gates %" is the dollar share among grants resolved to a registered U.S. nonprofit. "Sector %" is the share of $1M+ revenue 501(c)(3)s in each category by organization count (~97,300 organizations total). The comparison is a rough alignment indicator, not a strict like-for-like ratio.

    [DATA] [INFERRED] Category Q is the headline distortion: 2.2 percent of large U.S. nonprofits, 38 percent of Gates's matched dollars (18× over-index). Human services (P) receives almost nothing (0.1×). The Q over-index understates health emphasis — Gavi, the Global Fund, and WHO sit outside the matched U.S. set.

    Gift Sizing and Big Bets

    [DATA] The median grant was $500,000 and the mean was about $1.35 million, a gap that signals a long right tail. The distribution by dollars shows a barbell: most dollars sit in the $1M to $5M tier (37.5 percent), with another 43 percent stacked into grants of $5 million or more.

    Grant size bandCount% of grantsDollars (M)% of dollars
    Under $25K2311.7%$2.80.0%
    $25K to $100K1,0147.5%$660.4%
    $100K to $500K5,07137.5%$1,3507.4%
    $500K to $1M3,10823.0%$2,16011.8%
    $1M to $5M3,64026.9%$6,86037.5%
    $5M to $10M2672.0%$1,7709.7%
    $10M to $50M1531.1%$2,70014.8%
    Over $50M230.2%$3,39018.5%

    [DATA] The 443 grants of $5 million or more (3.3 percent of all grants by count) carry 43 percent of all dollars. The 23 grants of $50 million or more carry 19 percent on their own. This is a foundation that makes thousands of program grants, but its center of gravity is a small set of nine-figure commitments to global financing platforms.

    [DATA] [INFERRED] Read against MacArthur, the contrast is structural. MacArthur's grant-size distribution is dominated by the $100K to $1M band (51 percent of dollars), with a thin tail of $5M+ grants carrying 19 percent. Gates inverts that shape: the $1M to $5M band carries 38 percent of dollars, and grants of $5M and above carry another 43 percent. Gates writes unusually large checks across the middle and upper tiers, not just at the extreme tail.

    The Big-Bet Tail

    [DATA] All 23 grants of $50 million or more in the three-year window, the tail that drives 19 percent of total giving:

    YearRecipientAmountPurpose (as filed)
    2024Gavi Alliance$350.5MVaccine delivery
    2023Gavi Alliance$340.0MVaccine delivery
    2022Gavi Alliance$340.0MVaccine delivery
    2023Global Fund (AIDS, TB, Malaria)$287.5MGlobal health and development
    2024Global Fund$283.4MGlobal health and development
    2024Gates Medical Research Institute$276.6MEnterics, malaria, MNCH, TB
    2022Global Fund$247.3MGlobal health and development
    2022Gates Medical Research Institute$129.2MDiscovery, malaria, MNCH, TB
    2024Rotary Foundation$120.5MPolio
    2022World Health Organization$105.0MPolio
    2023Rotary Foundation$100.0MPolio
    2022Rotary Foundation$100.0MPolio
    2023Gates Medical Research Institute$93.7MDiscovery, malaria, MNCH, TB
    2023World Health Organization$87.0MPolio
    2023Gates Medical Research Institute$82.7MEnterics, malaria, MNCH, TB
    2024WHO (Pakistan)$65.0MPolio
    2022U.S. Fund for UNICEF$64.3MPolio
    2023U.S. Fund for UNICEF$58.0MPolio
    2022World Health Organization$55.2MPolio
    2024World Health Organization$52.0MPolio
    2023Pfizer$50.0MPneumonia and pandemic preparedness
    2023World Health Organization$50.0MPolio
    2022Pfizer$50.0MPneumonia

    [INFERRED] The $50M-plus tail is almost entirely three things: Gavi, the Global Fund, and the global polio campaign (Rotary, WHO, UNICEF), plus the foundation's own Gates Medical Research Institute. There is no grant of this size outside global health.

    Largest Partners

    [DATA] The top recipients by total dollars received across 2022 to 2024 (deduplicated; the World Health Organization figure aggregates its separate country-office filings):

    RecipientCountryGrants3-yr total
    World Health Organization (all offices)HQ Switzerland + field290$1,118.9M
    Gavi AllianceSwitzerland6$1,034.3M
    Global Fund (AIDS, TB, Malaria)Switzerland22$857.3M
    U.S. Fund for UNICEFUnited States131$652.4M
    Gates Medical Research InstituteUnited States7$620.8M
    PATHUnited States221$446.9M
    World Bank (IBRD)United States137$349.9M
    Rotary FoundationUnited States5$326.4M
    University of Washington FoundationUnited States134$282.2M
    Clinton Health Access InitiativeUnited States135$188.9M
    Johns Hopkins UniversityUnited States147$136.2M
    PfizerUnited States6$127.8M
    MMV (Medicines for Malaria Venture)Switzerland18$119.9M
    CIMMYT (maize and wheat research)Mexico36$117.8M
    New Venture FundUnited States49$110.6M

    [INFERRED] The Gates Medical Research Institute, the fifth-largest recipient, is a foundation-affiliated nonprofit R&D institute funded primarily by the Gates Foundation. It is funding directed into work the foundation closely shapes rather than an independent external grantee.

    Recipient Profile

    [DATA] Maturity. The median formation year among matched recipients (1,242 organizations with a known formation year) is 2000. The full distribution by era:

    FoundedRecipientsFoundedRecipients
    Pre-19501561990s166
    1950s312000s217
    1960s492010–2019341
    1970s902020+74
    1980s118

    [DATA] Scale. By revenue, the portfolio skews to large, established institutions: 213 of the matched recipients report over $100 million in annual revenue, including 92 over $500 million.

    [INFERRED] The median formation year of 2000 reflects a barbell of its own: a deep bench of pre-1950 and mid-century institutions (research universities and U.S.-based global-health institutions, including the U.S. Fund for UNICEF) alongside a large cohort of organizations founded since 2000, the era in which much of the modern global-health-delivery and education-reform infrastructure was created (often with Gates as an early funder). It is not a foundation that primarily seeds small, early-stage organizations; it funds institutions with the absorptive capacity to deploy eight- and nine-figure grants.

    Top University and Research-Institute Recipients

    [DATA] Three-year totals. The Gates Medical Research Institute is a foundation-affiliated R&D institute and is shown for completeness:

    RecipientCountry3-yr total
    Gates Medical Research InstituteUnited States$620.8M
    University of Washington FoundationUnited States$282.2M
    Johns Hopkins UniversityUnited States$136.2M
    HarvardUnited States$96.0M
    Emory UniversityUnited States$90.3M
    University of ManitobaCanada$87.9M
    University of OxfordUnited Kingdom$86.1M
    StanfordUnited States$69.5M
    JSI Research & Training InstituteUnited States$67.5M
    UC San FranciscoUnited States$63.8M
    Imperial College LondonUnited Kingdom$60.3M
    Scripps Research InstituteUnited States$56.3M
    Aga Khan UniversityPakistan$51.7M
    MITUnited States$50.4M

    [DATA] [INFERRED] U.S. research universities dominate the list, with significant secondary presence in Canada, the U.K., and Pakistan. The geographic concentration in Massachusetts, Maryland (Johns Hopkins), and Washington State traces directly to which universities receive the largest cumulative checks rather than to any place-based intent.

    Repeat-Recipient Structure

    [DATA] Funding concentration by years funded

    Years fundedRecipients% of recipientsDollars (B)% of dollars
    1 year1,40042.1%$1.095.9%
    2 years93228.0%$2.0311.1%
    All 3 years99129.8%$15.1883.0%

    [DATA] [INFERRED] The foundation's money is overwhelmingly committed to durable, multi-year relationships. The 30 percent of recipients funded in all three years captured 83 percent of the dollars, a sharper concentration than MacArthur's 8 percent / 31 percent equivalent. The portfolio reads less as a discretionary grants program than as a portfolio of named, multi-year institutional bets.

    The depth of repeat funding is the defining structural feature of the portfolio. Read together with the gift-size distribution, the operative pattern is a small set of very large institutional commitments, renewed annually, surrounded by a wider periphery of single-year program grants.

    One caveat on the one-year cohort: the three-year window cuts off recipient histories at both edges. An organization funded in 2019 and again in 2024 would appear here as a single-year recipient because earlier grants fall outside the available filings. The 42 percent single-year share is therefore an upper bound on genuinely one-time giving; the concentration finding is conservative.

    Intermediary and Regrantor Channels

    [DATA] Pooled funds, donor-advised intermediaries, and fiscal sponsors are a comparatively modest channel for Gates. The largest intermediary recipients, with their actual filed grant purposes:

    • American Online Giving Foundation ($47.8M): every grant is labeled "Employee matching gift, for general operating support." This is the foundation's employee-giving match program, not strategic regranting.
    • Co-Impact Philanthropic Funds ($34.0M): "Empower women and girls" ($15M) and "Community engagement grantmaking" ($19M).
    • Rockefeller Philanthropy Advisors ($30.5M, 31 grants): spread across many purposes, led by "Financial services for the poor," with "Empower women and girls," "Inclusive financial systems," "Family planning," "U.S. economic mobility and opportunity," "Postsecondary education," and "K-12 education."
    • Charter Fund Inc / Charter School Growth Fund ($16.8M): every grant labeled "K-12 education."

    [DATA] [INFERRED] Apart from the employee-match vehicle, the intermediary channel maps directly onto the foundation's own program areas (women and girls, financial inclusion, U.S. education) rather than functioning as open-ended regranting. Gates largely funds operating institutions directly, which fits a portfolio built around named multilateral platforms and research universities.

    [INFERRED] The relative absence of pooled-fund routing reflects the operating model. Gates underwrites the multilateral architecture directly (Gavi, the Global Fund, WHO) and the research-university base directly. These institutions function as their own redistribution layers, deploying Gates funding through their own grant and contract networks. The result is fewer intermediary-line items on the 990; whether much of this funding ultimately reaches smaller delivery organizations depends on each partner's internal subgrant flow, which is not visible in 990-PF data.

    Mission Language Patterns

    [DATA] Top substantive terms in grant-purpose text (excluding generic terms such as "support," "operating," and "general"). Grant count and total dollars for each key term (purpose text containing the word; word boundaries applied to short tokens):

    TermGrantsDollarsTermGrantsDollars
    vaccine723$2.85Btuberculosis402$1.05B
    polio432$2.36Bpneumonia460$1.54B
    malaria683$1.84Bdiagnostics438$1.14B
    maternal697$1.59Bgenomics438$1.14B
    newborn372$861Mepidemiology438$1.14B
    child698$1.62Bfamily planning527$963M
    nutrition566$1.26Bagricultural1,050$1.54B

    [DATA] Caveat: "diagnostics," "genomics," and "epidemiology" return identical figures (438 grants, $1.14B) because they appear together in a single recurring purpose label ("Enterics, Diagnostics, Genomics & Epidemiology"); they are one funding line, not three independent ones.

    [INFERRED] The notable absences are as telling as the presences: arts and culture, the environment and climate, criminal justice, and place-based community development barely register. This is a foundation with a tightly bounded thesis.

    [DATA] Artificial intelligence: not yet a funding line. Although AI is named as a forward priority in the foundation's 2025 spend-down announcement, a search of grant-purpose text for "artificial intelligence" or a standalone "AI" returns zero grants in the 2022 to 2024 window.

    [INFERRED] This is a genuine gap rather than a small share: by this measure, AI was not yet a labeled funding line in the period analyzed. The caveat is that grant-purpose text is terse, so AI-enabled work could be funded under a disease or tools label without naming the technology; we report only what the text states.


    §04 · Practical Implications

    [INFERRED] This analysis identifies portfolio composition, not selection criteria. The considerations below describe alignment with the demonstrated portfolio.

    Strongly represented profiles

    • Global health organizations working on vaccines, infectious disease, or maternal and child health
    • Research universities and institutes capable of translational science at scale
    • Multilateral and international NGOs delivering in low- and middle-income countries
    • U.S. education organizations focused on K-12 outcomes or postsecondary completion
    • Established institutions with the capacity to absorb multi-million-dollar, multi-year grants
    • Polio-eradication partners: WHO, U.S. Fund for UNICEF, Rotary
    • Agricultural-development organizations working in Sub-Saharan Africa and South Asia

    Underrepresented profiles

    • Arts, culture, and humanities organizations (0.2× the sector base rate)
    • Environment and climate organizations (0.5×)
    • Human services organizations (0.1× — the sharpest gap)
    • Place-based or community-development nonprofits outside the global-development frame
    • Small, early-stage, or sub-$1M organizations seeking general operating support
    • Organizations seeking one-time project grants with no path to a multi-year relationship
    • Direct human-services delivery in the United States

    For organizations seeking entry [REPORTED] [INFERRED] The data is consistent with one practical entry path: becoming a credible delivery partner within one of the foundation's named initiatives, often as a sub-grantee or consortium member of an organization already in the portfolio. The foundation's published grant-applicant materials state that it generally invites proposals directly and only occasionally awards grants through published RFPs; unsolicited proposals are rarely the route in. [10] For small operating nonprofits, the more realistic path is to work alongside a named partner (Gavi, the Global Fund, a major research university, a country-level implementing NGO) on a defined deliverable within an existing program.

    [REPORTED] [INFERRED] The May 2025 announcement reframes this picture forward: a doubling of annual giving against a fixed 2045 horizon points toward larger checks to institutions that can absorb them, not a broader base of new grantees.


    §05 · Limits of the Analysis

    Selection criteria. The foundation publishes program-area guidelines, but the majority of its grantmaking is invitation-driven and proposal-by-RFP. Portfolio composition reflects both deliberate strategy and the program teams' existing relationships and networks. This analysis cannot distinguish between what was chosen and what was already in the funnel.

    Probability of selection. A nonprofit working on, for example, agricultural development cannot infer odds of Gates funding from this analysis. The portfolio captures roughly 3,300 distinct funded organizations against an eligible universe in the hundreds of thousands. The dollar concentration on a small set of named institutions means that for most plausible applicants, the demonstrated funding probability is functionally zero, even before considering selection criteria.

    Causation. Correlation between organizational characteristics and selection is not evidence that Gates prefers them. The concentration in multilaterals may reflect a deliberate strategy of leveraging existing global-health architecture, or it may simply reflect that program teams' networks run through Geneva and a small number of named research universities. The data is consistent with both readings.

    The unmatched half. Sector, maturity, and revenue findings describe only the matched 501(c)(3) subset of the portfolio ($9.39B, 51.3 percent of dollars; see the recipient-type reconciliation in §03). U.S. university grants, U.S. for-profit/other grants (dominated by Pfizer), and international recipients (~47 percent of dollars) are absent from any analysis keyed to U.S. tax classifications. The true health and international-development share of the full portfolio is substantially higher than the matched 501(c)(3) figures alone suggest.

    Counterfactuals. This analysis describes who was funded. It does not describe who was rejected, who never applied, who would have done well with funding but did not receive it, or what the portfolio would look like if Gates pursued a different strategy. None of those questions is answerable from 990 filings.

    The three-year window. Recipient histories are truncated at both edges of the 2022 to 2024 window. An organization funded in 2019 and again in 2025 would appear here as a single-year recipient or as absent entirely, depending on which year fell inside the window. The repeat-recipient concentration finding (small core, most dollars) is conservative.

    The spend-down framing. The May 2025 announcement is forward-looking. The 2022 to 2024 data may not be representative of 2025 to 2045 grantmaking, especially given the doubling of annual giving and the fixed sunset. Inferences from current data to future portfolio shape should be treated as hypotheses.


    §06 · Methodology

    Source data. Grants extracted from the Gates Foundation's IRS Form 990-PF Schedule I filings for tax years 2022 to 2024, accessed via the SciRise Funding Intelligence dataset. Extracted annual totals reconcile to 100 percent of the official Part I grants-paid figure in all three years (13,507 grants totaling $18.3 billion).

    Recipient matching. Each grant recipient was resolved against the full U.S. 501(c)(3) population by EIN where possible. Recipients were deduplicated by a stable key (EIN when matched; otherwise a case-normalized name plus jurisdiction). The World Health Organization appears under multiple country-office jurisdictions; aggregated across offices it received roughly $1.1 billion, the single largest destination in the portfolio. The University of Washington appears under both a matched "Foundation" variant ($282.2M) and an unmatched name string (~$13.3M); combined, ~$295.5M.

    NTEE classification and base rate. Sector shares use NTEE major categories for matched U.S. recipients. The base-rate denominator is the population of U.S. 501(c)(3) organizations reporting $1M+ revenue in their most recent filing. Foundation share is measured by dollars; sector share by organization count.

    Evidence tags. [DATA] — claim directly supported by counts or figures derived from the underlying filings. [INFERRED] — pattern interpreted from data requiring analytical judgment; alternative explanations exist. [REPORTED] — drawn from the foundation's own public statements, named news outlets, or outside-analyst interpretation, not from the tax filings.

    References

    1. Bill & Melinda Gates Foundation. "Gates Foundation Will Double Spending Over Next 20 Years to Accelerate Progress on Saving and Improving Lives" (press release, May 8, 2025). https://www.gatesfoundation.org/ideas/media-center/press-releases/2025/05/25th-anniversary-announcement
    2. STAT News. "Bill Gates to accelerate spending at his foundation, then wind it down" (May 8, 2025). https://www.statnews.com/2025/05/08/bill-gates-foundation-accelerates-donations-plans-to-give-200-billion-by-2045/
    3. Inside Higher Ed. "Gates Foundation to Spend $200B Before Closing in 2045" (May 9, 2025). https://www.insidehighered.com/news/quick-takes/2025/05/09/gates-foundation-spend-200b-closing-2045
    4. Philanthropy News Digest. "Gates Foundation pledges to spend down $200 billion by 2045." https://philanthropynewsdigest.org/news/gates-foundation-pledges-to-spend-down-200-billion-by-2045
    5. Inside Philanthropy. "Gates Sets An End Date: 2045. But Do We Really Know How Much He'll Spend?" https://www.insidephilanthropy.com/home/gates-sets-an-end-date-2045-but-do-we-really-know-how-much-hell-spend
    6. Bill & Melinda Gates Foundation. "Gates Foundation Commits to Historic $9 Billion Annual Payout, Strengthens Stewardship to Maximize Mission Impact Through Closure in 2045" (press release, January 14, 2026). https://www.gatesfoundation.org/ideas/media-center/press-releases/2026/01/historic-annual-budget-to-accelerate-mission
    7. Wall Street Journal. "Gates Foundation to Cut 20% of Staff, Review Epstein Ties" (April 21, 2026).
    8. CNBC. "Gates Foundation reviewing Jeffrey Epstein ties, will slash 20% of staff, WSJ reports" (April 21, 2026). https://www.cnbc.com/2026/04/21/gates-foundation-jeffrey-epstein-jobs-cuts.html
    9. CDC Newsroom. "United States Completes WHO Withdrawal" (January 22, 2026). https://www.cdc.gov/media/releases/2026/united-states-completes-who-withdrawal.html
    10. Bill & Melinda Gates Foundation. "Grant applicant FAQ." https://www.gatesfoundation.org/about/how-we-work/grant-applicant-faq

    §07 · Reference

    About the Foundation

    NameBill & Melinda Gates Foundation
    AddressPO Box 23350, Seattle, WA 98102
    Phone(206) 709-3100
    Websitewww.gatesfoundation.org
    EIN56-2618866

    This is an independent analysis. Findings reflect public 990 filings and authoritative reporting only, and do not represent any communication from the Bill & Melinda Gates Foundation. Errors and interpretations are the author's.

    End of report · 2026

    Questions?